X-Square Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$456K Buy
380
+53
+16% +$54.2K 0.12% 134
2026
Q1
$301K Buy
327
+8
+3% +$8.11K 0.1% 146
2025
Q4
$343K Buy
319
+6
+2% +$5.74K 0.11% 136
2025
Q3
$239K Hold
313
0.07% 149
2025
Q2
$244K Buy
313
+2
+0.6% +$1.55K 0.09% 146
2025
Q1
$257K Sell
311
-100
-24% -$83.2K 0.11% 138
2024
Q4
$317K Buy
+411
New +$340K 0.13% 134

Other funds holding LLY

X-Square Capital's LLY Position: Q2 2026 in Review

X-Square Capital increased its Eli Lilly (LLY) stake by 16% in Q2 2026, buying an estimated $54.2K and bringing the position to 380 shares worth $456K. The position accounts for 0.12% of the portfolio, ranked #134.

X-Square Capital first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • X-Square Capital held 380 shares of Eli Lilly worth $456K as of Q2 2026.
  • X-Square Capital bought 53 Eli Lilly shares in Q2 2026, an estimated $54.2K.
  • Eli Lilly made up 0.12% of X-Square Capital's portfolio in Q2 2026, its #134 holding.
  • X-Square Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on X-Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.